See also this year's filing and all EDGAR filings for this company.
PDF Report 0001447028_2023_Arbutus_Biopharma_Corp.pdf
Logs
Graph
Absolute values for 0001447028, Arbutus Biopharma Corp
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 151,139,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 5,070,000 |
3 | remainder_Assets | 39,210,000 |
4 | LiabilitiesCurrent | 32,857,000 |
5 | LiabilitiesNoncurrent | 1,815,000 |
6 | remainder_Liabilities | 23,895,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 17,834,000 |
9 | ResearchAndDevelopmentExpense | 84,408,000 |
10 | remainder_Expenses | 6,677,000 |
11 | remainder_Revenues | 39,019,000 |
12 | remainder_NetIncome | 444,000 |
13 | remainder_ComprehensiveNetIncome | -2,153,000 |
yvar | yval | |
---|---|---|
0 | Assets | 195,419,000 |
1 | Liabilities | 58,567,000 |
2 | Expenses | 108,919,000 |
3 | Revenues | 39,019,000 |
4 | StockholdersEquity | 136,852,000 |
5 | NetIncome | -69,456,000 |
6 | ComprehensiveNetIncome | -70,532,500 |
7 | BaseVar | 202,260,500 |
8 | EconomicCapitalRatio | 1.30 |